Search Count: 38
All
Selected
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2026-04-15 Classification: TRANSFERASE Ligands: A1C65, GOL, SO4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2026-04-15 Classification: TRANSFERASE Ligands: A1C66, GOL, SO4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2026-04-15 Classification: TRANSFERASE Ligands: A1C67, EDO, GOL, SO4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.98 Å Release Date: 2025-01-01 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: A1AFR, GOL, SO4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2025-01-01 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: TZ0, SO4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.23 Å Release Date: 2025-01-01 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: TZ0, SO4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.04 Å Release Date: 2025-01-01 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: TZ0, GOL, SO4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.94 Å Release Date: 2024-09-25 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: EDO, A1AV2, SO4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.53 Å Release Date: 2024-09-25 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: A1AV2, GOL, SO4 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2020-02-12 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: N9G |
 |
Discovery Of A Novel, Highly Potent, And Selective Thieno[3,2-D]Pyrimidinone-Based Cdc7 Inhibitor With A Quinuclidine Moiety (Tak-931) As An Orally Active Investigational Anti-Tumor Agent
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.65 Å Release Date: 2020-01-15 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: O1S |
 |
Discovery Of A Novel, Highly Potent, And Selective Thieno[3,2-D]Pyrimidinone-Based Cdc7 Inhibitor With A Quinuclidine Moiety (Tak-931) As An Orally Active Investigational Anti-Tumor Agent
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.30 Å Release Date: 2020-01-15 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: O1V |
 |
Identification Of Novel, Potent And Selective Gcn2 Inhibitors As First-In-Class Anti-Tumor Agents
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.61 Å Release Date: 2019-10-09 Classification: transferase/transferase inhibitor Ligands: KAV |
 |
Identification Of Novel, Potent And Selective Gcn2 Inhibitors As First-In-Class Anti-Tumor Agents
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.01 Å Release Date: 2019-10-09 Classification: transferase/transferase inhibitor Ligands: KA4 |
 |
Identification Of Novel, Potent And Selective Gcn2 Inhibitors As First-In-Class Anti-Tumor Agents
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2019-10-09 Classification: transferase/transferase inhibitor Ligands: KA7 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.47 Å Release Date: 2019-07-17 Classification: nuclear protein/agonist Ligands: SO4, MPD, HQ7 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2019-06-12 Classification: nuclear protein/agonist Ligands: EDO, HOJ |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.48 Å Release Date: 2018-11-21 Classification: signaling protein/antagonist Ligands: CF7 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.18 Å Release Date: 2018-08-01 Classification: signaling protein/agonist Ligands: CFJ |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.18 Å Release Date: 2018-03-21 Classification: transcription/agonist Ligands: MPD, E3S |